BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity.EBI
Universit£
De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one¿-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex Vivo.EBI
Universit£
Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.EBI
University of Naples&Quot;Federico Ii&Quot
Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.EBI
Universit£
Deconstruction of sulfonamide inhibitors of the urotensin receptor (UT) and design and synthesis of benzylamine and benzylsulfone antagonists.EBI
Boehringer Ingelheim Pharmaceuticals
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.EBI
University of Naples Federico Ii
Urotensin-II receptor modulators as potential drugs.EBI
Johnson & Johnson Pharmaceutical Research & Development
Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.EBI
Johnson & Johnson Pharmaceutical Research & Development
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.EBI
Johnson & Johnson Pharmaceutical Research & Development
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.EBI
University of Naples "Federico Ii
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954).EBI
Acadia Pharmaceuticals
Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.EBI
Universit£
Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics.EBI
Universit£
Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3ß Inhibitors with Anti-inflammatory Potential.BDB
Hamdard University (Jamia Hamdard)